Hodgkin Disease Refractory
2 clinical trials · Condition
◉ Watch Hodgkin Disease Refractory
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT) (NCT04268706) | Tessa Therapeutics | 2021-02-01 |
Track Hodgkin Disease Refractory automatically
Every clearance here is in the API, with alerts when new ones post.